Ironwood医药(IRWD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IRWD Ironwood医药

已收盘 07-31 16:00:00 EDT

4.23

+0.50

+13.40%

盘后4.32

+0.09+2.11%

19:58 EDT

最高4.28	最低3.87	成交量358.34万
今开3.93	昨收3.73	日振幅10.86%
总市值6.96亿	流通市值5.71亿	总股本1.65亿
成交额1,480万	换手率2.65%	流通股本1.35亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IRWD","market":"US","secType":"STK","nameCN":"Ironwood医药","latestPrice":4.23,"timestamp":1785528000000,"preClose":3.73,"halted":0,"volume":3583359,"hourTrading":{"tag":"盘后","latestPrice":4.3194,"preClose":4.23,"latestTime":"19:58 EDT","volume":48293,"amount":205135.7699,"timestamp":1785542339367,"change":0.0894,"changeRate":0.021135,"amplitude":0.03773},"delay":0,"changeRate":0.13404825737265427,"floatShares":135000000,"shares":164613406,"eps":0.5973,"marketStatus":"已收盘","change":0.5,"latestTime":"07-31 16:00:00 EDT","open":3.93,"high":4.275,"low":3.87,"amount":14797334.072780998,"amplitude":0.108579,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.5973,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785744000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1265173200000,"exchange":"NASDAQ","adjPreClose":3.73,"preHourTrading":{"tag":"盘前","latestPrice":3.93,"preClose":3.73,"latestTime":"09:29 EDT","volume":42476,"amount":164690.3810748,"timestamp":1785504599999,"change":0.2,"changeRate":0.053619,"amplitude":0.117962},"postHourTrading":{"tag":"盘后","latestPrice":4.3194,"preClose":4.23,"latestTime":"19:58 EDT","volume":48293,"amount":205135.7699,"timestamp":1785542339367,"change":0.0894,"changeRate":0.021135,"amplitude":0.03773},"volumeRatio":2.41684,"impliedVol":1.1603,"impliedVolPercentile":0.4821},"requestUrl":"/m/hq/s/IRWD","defaultTab":"news","newsList":[{"id":"1117919813","title":"Ironwood医药启动Apraglutide三期Stars-2试验，六月起招募患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1117919813","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117919813?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:32","pubTimestamp":1784028769,"startTime":"0","endTime":"0","summary":"Ironwood医药公司已正式启动其候选药物Apraglutide的三期临床试验，项目代号为Stars-2。该试验计划于六月开始，目前正在积极招募符合条件的患者参与。这项研究标志着Apraglutide在研发进程中的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197384558","title":"Ironwood医药任命Jeffrey Silber博士为首席医疗官兼研发负责人；STARS-2试验六月启动，现正积极招募患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1197384558","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197384558?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:32","pubTimestamp":1784028743,"startTime":"0","endTime":"0","summary":"Ironwood医药宣布了一项重要的人事任命与临床试验进展。Jeffrey Silber博士被正式任命为公司首席医疗官，并同时兼任研究与药物开发部门的负责人。这一任命旨在加强公司研发管线与临床开发战略的领导力。\n与此同时，公司备受关注的STARS-2临床试验已于今年六月正式启动。该试验目前正处于患者招募的活跃阶段，标志着相关研究项目进入了关键的临床实施环节。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109542568","title":"FDA批准Linzess用于治疗两岁及以上儿童功能性便秘","url":"https://stock-news.laohu8.com/highlight/detail?id=1109542568","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109542568?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:54","pubTimestamp":1779893682,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已批准将Linzess（利那洛肽）的适用范围扩展至两岁及以上的儿童功能性便秘患者。\n然而，该药物对于两岁以下患儿存在严重脱水风险，因此在此年龄段禁用。此外，对于已知或疑似存在机械性胃肠道梗阻的患者，Linzess同样为禁忌用药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142759565","title":"Ironwood医药旗下Linzess因严重脱水风险禁用于两岁以下患儿","url":"https://stock-news.laohu8.com/highlight/detail?id=1142759565","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142759565?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:05","pubTimestamp":1779890721,"startTime":"0","endTime":"0","summary":"Ironwood医药公司宣布，其产品Linzess（利那洛肽）因存在引发严重脱水的潜在风险，现明确禁用于两岁以下患者群体。这一更新基于对药物安全性的持续评估，旨在进一步保障儿童用药安全。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150639050","title":"Ironwood医药：已知或疑似机械性胃肠道梗阻患者禁用Linzess","url":"https://stock-news.laohu8.com/highlight/detail?id=1150639050","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150639050?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:01","pubTimestamp":1779890508,"startTime":"0","endTime":"0","summary":"Ironwood医药公司明确指出，其产品Linzess禁止用于已知或疑似存在机械性胃肠道梗阻的患者。该禁忌症强调了在特定病理状态下使用该药物的潜在风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149713974","title":"FDA批准利那洛肽用于两岁及以上功能性便秘儿科患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1149713974","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149713974?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:00","pubTimestamp":1779890420,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已正式批准利那洛肽用于治疗两岁及以上年龄儿童的功能性便秘。这一决定标志着该药物在儿科适应症上的重要扩展，为患有此类慢性消化系统疾病的低龄患者提供了一种新的治疗选择。利那洛肽是一种鸟苷酸环化酶-C激动剂，此前已获准用于成人慢性特发性便秘和肠易激综合征伴便秘的治疗。功能性便秘在儿童中是一种常见疾病，此次批准有望为众多受此困扰的患儿及其家庭带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189060226","title":"Ironwood医药任命罗纳德·西尔弗为临时首席财务官，2026年5月15日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1189060226","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189060226?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:02","pubTimestamp":1778673736,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，Ironwood医药公司已任命罗纳德·西尔弗为临时首席财务官，该任命自2026年5月15日起正式生效。此项人事变动标志着公司财务领导层进入过渡阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119325038","title":"Ironwood医药公布2026年第一季度强劲业绩：Linzess美国净销售额同比激增97% 维持全年财务指引不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1119325038","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119325038?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:07","pubTimestamp":1778152071,"startTime":"0","endTime":"0","summary":"Ironwood医药（IRWD）2026年第一季度业绩表现亮眼，其核心产品Linzess在美国市场的净销售额实现同比97%的显著增长。尽管取得如此强劲的开局，该公司仍决定维持此前发布的2026年全年财务业绩指引，显示出管理层对年度目标的审慎信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141471149","title":"Ironwood医药公司循环信贷额度到期日维持2028年12月31日不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1141471149","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141471149?lang=zh_cn&edition=full","pubTime":"2026-03-11 19:12","pubTimestamp":1773227550,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，Ironwood医药公司（Ironwood Pharmaceuticals）现有循环信贷额度的最终到期日将保持不变，仍定为2028年12月31日。\n这一信息确认了该公司关键融资工具的期限结构，为市场提供了其长期财务规划的重要参考依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616036123","title":"Ironwood医药盘中异动 股价大涨5.26%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616036123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616036123?lang=zh_cn&edition=full","pubTime":"2026-03-03 01:30","pubTimestamp":1772472648,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日01时30分，Ironwood医药股票出现波动，股价大幅上涨5.26%。截至发稿，该股报3.60美元/股，成交量103.55万股，换手率0.64%，振幅10.09%。Ironwood医药股票所在的制药行业中，整体跌幅为1.78%。Ironwood医药公司简介：Ironwood Pharmaceuticals Inc是一家专业和仿制药制造公司，经营人类治疗部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030301304897a7b3f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030301304897a7b3f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146529260","title":"Ironwood医药公布2025年第四季度及全年业绩 达成财务目标并重申2026年强劲展望","url":"https://stock-news.laohu8.com/highlight/detail?id=1146529260","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146529260?lang=zh_cn&edition=full","pubTime":"2026-02-25 20:07","pubTimestamp":1772021238,"startTime":"0","endTime":"0","summary":"Ironwood医药今日正式披露2025年第四季度及全年财务报告。公司不仅全面达成去年设定的财务指引目标，更以稳健数据为基础重申对2026年业务发展的强劲预期。\n在复杂多变的市场环境中，这家专注于胃肠道疾病创新疗法的生物制药企业展现出卓越的运营韧性。其核心产品线的商业化进展与研发管线的战略布局，为未来增长注入持续动能。\n值得注意的是，公司管理层在财报中强调，2025年各项关键绩效指标均符合或超越预期，这一成果为2026年的战略推进奠定了坚实基础。随着全球医疗需求的持续演化，Ironwood医药通过精准的市场定位与高效的资源调配，正持续巩固其在专科治疗领域的竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610950425","title":"Ironwood医药盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610950425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610950425?lang=zh_cn&edition=full","pubTime":"2026-02-11 23:19","pubTimestamp":1770823140,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日23时19分，Ironwood医药股票出现异动，股价快速跳水5.01%。截至发稿，该股报4.36美元/股，成交量51.3751万股，换手率0.32%，振幅6.21%。Ironwood医药股票所在的制药行业中，整体涨幅为0.09%。Ironwood医药公司简介：Ironwood Pharmaceuticals Inc是一家专业和仿制药制造公司，经营人类治疗部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602112319009540c853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602112319009540c853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610478006","title":"Ironwood医药盘中异动 股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610478006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610478006?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:31","pubTimestamp":1770647491,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时31分，Ironwood医药股票出现波动，股价大幅上涨5.48%。截至发稿，该股报4.81美元/股，成交量13.6945万股，换手率0.08%，振幅2.19%。Ironwood医药股票所在的制药行业中，整体涨幅为1.48%。其相关个股中，脑再生科技、诺和诺德、Ironwood医药涨幅较大，苏轩堂、Biofrontera Inc.、Hims & Hers Health, Inc.较为活跃，换手率分别为367.12%、71.34%、4.53%，振幅较大的相关个股有Biofrontera Inc.、苏轩堂、Ironwood医药，振幅分别为15.47%、11.33%、4.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922313197a581a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922313197a581a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518899275","title":"Ironwood医药盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518899275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518899275?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:29","pubTimestamp":1741616947,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时29分，Ironwood医药股票出现波动，股价急速跳水5.00%。截至发稿，该股报1.43美元/股，成交量18.5704万股，换手率0.12%，振幅4.00%。Ironwood医药股票所在的制药行业中，整体跌幅为2.09%。Ironwood医药公司简介：Ironwood Pharmaceuticals Inc 是一家专业和仿制药制造公司，经营人类治疗部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222907a26a3add&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222907a26a3add&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517581264","title":"Ironwood医药2024财年实现净利润1.81百万美元，同比增加100.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517581264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517581264?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363235,"startTime":"0","endTime":"0","summary":"3月8日，Ironwood医药公布财报，公告显示公司2024财年净利润为1.81百万美元，同比增加100.18%；其中营业收入为3.51亿美元，同比减少20.77%，每股基本收益为0.01美元。从资产负债表来看，Ironwood医药总负债6.53亿美元，其中短期债务3.19百万美元，资产负债比为0.54，流动比率为0.05。机构评级：截至2025年3月8日，当前有6家机构对Ironwood医药目标价做出预测，其中目标均价为8.67美元，其中最低目标价为3.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000044a2647e53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000044a2647e53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517193058","title":"Ironwood医药盘中异动 快速跳水5.19%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193058","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517193058?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:39","pubTimestamp":1741282792,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时39分，Ironwood医药股票出现异动，股价急速下挫5.19%。截至发稿，该股报1.46美元/股，成交量52.2718万股，换手率0.33%，振幅5.52%。最近的财报数据显示，该股实现营业收入3.51亿美元，净利润1.81百万美元，每股收益0.01美元，毛利3.49亿美元，市盈率146.50倍。Ironwood医药股票所在的制药行业中，整体跌幅为1.56%。Ironwood医药公司简介：Ironwood Pharmaceuticals Inc 是一家专业和仿制药制造公司，经营人类治疗部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307013953963c6ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307013953963c6ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516773726","title":"Ironwood医药盘中异动 急速跳水5.59%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516773726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516773726?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:33","pubTimestamp":1741098801,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时33分，Ironwood医药股票出现异动，股价快速下挫5.59%。截至发稿，该股报1.44美元/股，成交量14.5595万股，换手率0.09%，振幅3.62%。Ironwood医药股票所在的制药行业中，整体跌幅为0.13%。Ironwood医药公司简介：Ironwood Pharmaceuticals Inc 是一家专业和仿制药制造公司，经营人类治疗部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223322963944ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223322963944ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516665662","title":"Ironwood医药盘中异动 临近收盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516665662?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:00","pubTimestamp":1741035619,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日05时00分，Ironwood医药股票出现异动，股价大幅跳水5.59%。截至发稿，该股报1.52美元/股，成交量249.974万股，换手率1.56%，振幅8.70%。Ironwood医药股票所在的制药行业中，整体涨幅为0.82%。Ironwood医药公司简介：Ironwood Pharmaceuticals Inc 是一家专业和仿制药制造公司，经营人类治疗部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050019a25dabac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050019a25dabac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IRWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514516385","title":"Ironwood医药盘中异动 早盘大幅上涨10.53%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514516385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514516385?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666722,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Ironwood医药股票出现波动，股价急速拉升10.53%。截至发稿，该股报1.89美元/股，成交量8.4932万股，换手率0.05%，振幅5.26%。Ironwood医药股票所在的制药行业中，整体涨幅为0.15%。其相关个股中，Ironwood医药、Medicus Pharma Ltd.、Therapeuticsmd, Inc.涨幅较大，苏轩堂、Petros Pharmaceuticals, Inc.、大自然药业较为活跃，换手率分别为6.22%、5.68%、3.25%，振幅较大的相关个股有Medicus Pharma Ltd.、Ironwood医药、苏轩堂，振幅分别为9.93%、5.26%、4.36%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223202a2567a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223202a2567a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRWD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120448340","title":"Ironwood Pharmaceuticals 2024年第四季度调整后每股收益为0.02美元，低于预期的0.08美元，销售额为9055万美元，低于预期的9382万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120448340","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120448340?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:10","pubTimestamp":1740658207,"startTime":"0","endTime":"0","summary":"Ironwood Pharmaceuticals  公布的季度每股收益为0.02美元，低于分析师预期的0.08美元，相差75%。公司报告的季度销售额为9055万美元，低于分析师预期的9382万美元，相差3.49%。相比去年同期的销售额1.1755亿美元，下降了22.98%。以上内容来自Benzinga Earnings专栏，原文如下：Ironwood Pharmaceuticals  reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.08 by 75 percent.  The company reported quarterly sales of $90.55 million which missed the analyst consensus estimate of $93.82 million by 3.49 percent.  This is a 22.98 percent decrease over sales of $117.55 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ironwood Pharmaceuticals 2024年第四季度调整后每股收益为0.02美元，低于预期的0.08美元，销售额为9055万美元，低于预期的9382万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRWD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ironwoodpharma.com","stockEarnings":[{"period":"1week","weight":-0.0158},{"period":"1month","weight":-0.114},{"period":"3month","weight":-0.1599},{"period":"6month","weight":-0.2372},{"period":"1year","weight":3.4773},{"period":"ytd","weight":0.1068}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ironwood Pharmaceuticals, Inc.于1998年1月5日在特拉华州注册成立。2008年4月7日，公司从Microbia，Inc.更名为Ironwood Pharmaceuticals, Inc.。Ironwood Pharmaceuticals是S & P SmallCap 600旗下公司，是一家领先的胃肠道（GI）医疗保健公司，其使命是推动GI疾病的治疗，并重新定义GI患者的护理标准。他们是开发LINZESS（利纳洛肽）的先驱，这是美国品牌处方市场的领导者，用于治疗伴有便秘的成人肠易激综合征（IBS-C）或慢性特发性便秘（CIC）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038536},{"month":2,"riseRate":0.375,"avgChangeRate":-0.040866},{"month":3,"riseRate":0.588235,"avgChangeRate":0.028778},{"month":4,"riseRate":0.176471,"avgChangeRate":-0.049797},{"month":5,"riseRate":0.470588,"avgChangeRate":-0.023139},{"month":6,"riseRate":0.823529,"avgChangeRate":0.035784},{"month":7,"riseRate":0.411765,"avgChangeRate":-0.006228},{"month":8,"riseRate":0.1875,"avgChangeRate":-0.031438},{"month":9,"riseRate":0.375,"avgChangeRate":-0.016086},{"month":10,"riseRate":0.5,"avgChangeRate":0.024919},{"month":11,"riseRate":0.625,"avgChangeRate":0.098606},{"month":12,"riseRate":0.5,"avgChangeRate":0.012771}],"exchange":"NASDAQ","name":"Ironwood医药","nameEN":"Ironwood Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ironwood医药(IRWD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ironwood医药(IRWD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ironwood医药,IRWD,Ironwood医药股票,Ironwood医药股票老虎,Ironwood医药股票老虎国际,Ironwood医药行情,Ironwood医药股票行情,Ironwood医药股价,Ironwood医药股市,Ironwood医药股票价格,Ironwood医药股票交易,Ironwood医药股票购买,Ironwood医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ironwood医药(IRWD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ironwood医药(IRWD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}